Literature DB >> 11083210

Laparoscopic radiofrequency thermal ablation of hepatocarcinoma: preliminary experience.

O Goletti1, R Lencioni, N Armillotta, A Puglisi, P V Lippolis, L Lorenzetti, D Cioni, B Musco, C Bartolozzi, E Cavina.   

Abstract

The objective was to evaluate the feasibility, safety, and effectiveness of radiofrequency thermal ablation (RFT), performed during laparoscopy with a cooled-tip electrode needle, in the treatment of neoplastic hepatic focal lesions. Seven patients with hepatocarcinoma (10 hepatic lesions) were treated during laparoscopy with RFT using a 100-watt RF generator and 17-gauge, dual-lumen, cooled-tip electrode needles with a 3-cm exposed tip. The mean exposure time was 12 minutes for each needle insertion. Spiral computed tomography scanning detected complete tumor necrosis in nine lesions; in one lesion, peripheral neoplastic tissue was detected, and percutaneous RFT was performed. Two patients during follow-up developed two new neoplastic lesions, treated with percutaneous ethanol injection. No recurrences of the treated lesions were seen after 6 months of follow up. Intraoperative RFT with a cooled-tip electrode needle is a safe and effective local treatment of hepatic focal lesions during laparoscopic surgery. Possible indications are large hepatocarcinoma (>5 cm), superficial lesions, multiple lesions, or tumor located near vascular or biliary structures.

Entities:  

Mesh:

Year:  2000        PMID: 11083210

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  9 in total

Review 1.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

2.  Laparoscopic radiofrequency of hepatocellular carcinoma using ultrasound-guided selective intrahepatic vascular occlusion.

Authors:  R Santambrogio; M Costa; M Barabino; E Opocher
Journal:  Surg Endosc       Date:  2008-02-05       Impact factor: 4.584

3.  Laparoscopic radiofrequency ablation of hepatocellular carcinoma: A critical review from the surgeon's perspective.

Authors:  R Santambrogio; E Opocher; M Montorsi
Journal:  J Ultrasound       Date:  2008-02-08

Review 4.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

Review 5.  Laparoscopic thermoablation for hepatocellular carcinoma in patients with liver cirrhosis: an effective procedure for tricky tumors.

Authors:  Roberto Santambrogio; Matteo Barabino; Valentina D'Alessandro; Elisa Galfrascoli; Marco Antonio Zappa; Gaetano Piccolo; Massimo Zuin; Enrico Opocher
Journal:  Med Oncol       Date:  2020-03-19       Impact factor: 3.064

6.  The physiologic effect of the pneumoperitoneum on radiofrequency ablation.

Authors:  M K Smith; D Mutter; L E Forbes; S Mulier; J Marescaux
Journal:  Surg Endosc       Date:  2003-11-21       Impact factor: 4.584

7.  Safety and efficacy of laparoscopic radiofrequency ablation for hepatic malignancies.

Authors:  Seung Duk Lee; Ho-Seong Han; Jai Young Cho; Yoo-Seok Yoon; Dae Wook Hwang; Kyuwhan Jung; Chang Jin Yoon; Yujin Kwon; Ji Hoon Kim
Journal:  J Korean Surg Soc       Date:  2012-06-26

8.  Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  R Santambrogio; M Podda; M Zuin; E Bertolini; S Bruno; G P Cornalba; M Costa; M Montorsi
Journal:  Surg Endosc       Date:  2003-06-17       Impact factor: 4.584

9.  Early experience with laparoscopic treatment of liver tumors using a separable cluster electrode with a no-touch technique.

Authors:  Hyun Pyo Hong; Jee Youn Lee; Mi Yeon Lee; Kyung Uk Jung; Byung Ik Kim; Byung Ho Son; Jun Ho Shin; Sung Ryol Lee
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-05-10       Impact factor: 1.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.